ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 665103 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 665103; 2) Community: the network communities that were significantly associated with the response to NSC 665103; 3) Molecule: the relationships between components within communities and NSC 665103; 4) MDR: the compounds that were significantly associated with the NSC 665103.

NSC Compound Enrichment Correlation
NSC 712733 Null 0.00182957917645007 0.72481535
NSC 728132 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,4-dichlorobenzene 0.00182957917645007 0.4934239
NSC 742838 7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl-, hydrochloride 0.00182957917645007 0.4706996
NSC 759322 MEVASTATIN 0.00182957917645007 -0.17211854
NSC 99027 Null 0.00182957917645007 0.60172899
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.00216534295403404 0.15985557
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.00216534295403404 0.60117608
NSC 45236 Null 0.00216534295403404 0.27190713
NSC 681632 Camptothecin Derivative 0.00216534295403404 0.095256796
NSC 724623 cyano pyridine -P-CH3 0.00216534295403404 0.18458363
Total:135  Current:12    [First] [Prev] [Next] [Last]